Volume 9 Number 3

Editorial

The Journal Citation Reports® Impact Factor: annual results 2012

Cummins P, Serruys PW

10.4244/EIJV9I3A48

free

Personalised antiplatelet therapy: are we ready for prime time? Data from China

Li J, Huo Y

10.4244/EIJV9I3A49

free

Clinical assessment, platelet reactivity measurement or genetic testing after acute coronary syndrome? What benefits the patient?

Keßler M, Rottbauer W, Koenig W

10.4244/EIJV9I3A50

free

Polymer coatings on drug-eluting stents: Samson’s hair and Achilles’ heel?

Basalus M, Joner M, von Birgelen C, Byrne RA

10.4244/EIJV9I3A51

free

Clinical research

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Meredith I, Verheye S, Weissman N, Barragan P, Scott D, Valdés Chávarri M, West N, Kelbæk H, Whitbourn R, Walters D, Kubica J, Thuesen L, Masotti M, Banning A, Sjogren I, Stables R, Allocco DJ, Dawkins K

10.4244/EIJV9I3A52

free

The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation

Liang Z-Y, Han Y, Zhang X-L, Li Y, Yan C-H, Kang J

10.4244/EIJV9I3A53

free

Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trial

Jiménez-Quevedo P, Hernando L, Gomez-Hospital J, Iñiguez A, San Román A, Alfonso F, Hernández-Antolín R, Angiolillo D, Banuelos C, Escaned J, Gonzalo N, Fernandez C, Macaya C, Sabaté M

10.4244/EIJV9I3A54

free

Long-term comparison of everolimus-eluting and biolimus-eluting stents

Puricel S, Oberhänsli M, Guntern P, Lehmann S, Goy J-J, Arroyo D, Villeneuve H, Baeriswyl G, Stauffer J-C, Togni M, Cook S

10.4244/EIJV9I3A55

free

Full conversion from transfemoral to transradial approach for percutaneous coronary interventions results in a similar success rate and a rapid reduction of in-hospital cardiac and vascular major events

Dangoisse V, Guedes A, Gabriel L, Jamart J, Chenu P, Marchandise B, Schroeder E

10.4244/EIJV9I3A56

free

Incidence, time course and predictors of early vs. late target lesion revascularisation after everolimus-eluting stent implantation: a SPIRIT V substudy

Niccoli G, Stuteville M, Sudhir K, Li D, Montone R, Bolognese L, Grube E

10.4244/EIJV9I3A57

free

The impact of gender on fractional flow reserve measurements

Fineschi M, Guerrieri G, Orphal D, Palmerini E, Munzel T, Warnholtz A, Pierli C, Gori T

10.4244/EIJV9I3A58

free

Gender differences in patients undergoing TAVI: a multicentre study

D’ascenzo F, Gonella A, Moretti C, Omedè P, Salizzoni S, La Torre M, Giordana F, Barbanti M, Ussia G, Brambilla N, Bedogni F, Gaita F, Tamburino C, Sheiban I

10.4244/EIJV9I3A59

free

Panasewicz A, Pedersen S, Veenhuis S, Oemrawsingh R, van der Giessen WJ, van Geuns R, Regar E, de Jaegere P, Serruys PW, van Domburg R

10.4244/EIJV9I3A60

free

Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study

Marchese N, Pacilli M, Inchingolo V, Fanelli F, Loperfido F, Vigna C

10.4244/EIJV9I3A61

free